Article

Alcon launches two new vitrectomy technologies

Alcon Laboratories has introduced two vitrectomy technologies designed to help surgeons deliver a higher level of precision and efficiency during retina surgery.

 

Fort Worth, TX-Alcon Laboratories has introduced two vitrectomy technologies designed to help surgeons deliver a higher level of precision and efficiency during retina surgery.

The two technologies were unveiled last week at the American Society of Retina Specialists annual meeting in San Diego.

More from this issue: AMA wants Sunshine Act database publication delayed

The Ultravit high-speed vitrectomy probe operates at an ultra-high-speed of 7,500 cpm, according to Alcon, and the increased speed helps reduce traction that can cause iatrogenic tears and postoperative complications.

The probe also features a dual-pneumatic drive that helps enable flow and shearing at high cut rates.

 

According to the company, the dual-pneumatic technology-in conjunction with Constellation duty cycle control-supports surgeons performing a wide range of maneuvers addressing several pathologies.

Alcon also introduced a new portfolio of 27+ series instruments and accessories that are designed to allow surgeons to reduce incision size and provide access to small tissue planes with a stiffness experience similar to 25+ instrumentation.

Both technologies are now available in the United States.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.